Skip to main content
. 2022 Jan 11;12(1):e050843. doi: 10.1136/bmjopen-2021-050843

Table 1.

Results of subgroup analysis of renal composite outcome events

Subgroup Number of trials n RR (95% CI) P value for RR I2 P value for heterogeneity test*
Study type
 RCT 1 418 0.64 (0.43 to 0.98) 0.04 0.76
 Cohort study 9 9160 0.72 (0.57 to 0.90) 0.005 88.6%
Baseline eGFR (mL/min/1.73 m2)
 60–89 1 171 0.14 (0.02 to 1.14) 0.07 0.48
 30–59 7 8869 0.71 (0.55 to 0.92) 0.009 90.8%
 15–29 2 538 0.77 (0.63 to 0.94) 0.01 0.0%
Mean age (years)
 <58 5 5691 0.58 (0.49 to 0.70) <0.001 56.4% 0.03
 ≥58 5 3887 0.85 (0.69 to 1.05) 0.14 70.1%
Baseline BP (mm Hg)
 <140/90 6 5806 0.62 (0.52 to 0.73) <0.001 58.5% 0.32
 SBP ≥140 or DBP ≥90 2 1646 0.70 (0.44 to 1.11) 0.13 74.6%
Comparator of control group
 Usual care or usual diet 2 589 0.43 (0.11 to 1.64) 0.21 50.2% 0.12
 Different levels of sodium intake 8 8989 0.73 (0.58 to 0.92) 0.008 89.8%
  • The bold P value indicates that there are statistical differences between subgroups.

*P value calculated by meta-regression.

BP, blood pressure; DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; n, number of patients; RCT, randomised controlled trial; RR, relative risk; SBP, systolic blood pressure.